Navigation Links
Gene determines pain threshold...

According to researchers, a gene determines people’s sensitivity to pain.In the study conducted on rats, the development// of chronic pain could be prevented by blocking the expression of that particular gene after a nerve injury or inflammation. This could be a breakthrough in development of new painkillers.

"Studies in volunteers showed that about a quarter of them had the genetic variant that protects them from pain somewhat, and three percent carried two mutated copies that make them exceptionally insensitive to pain, " the researchers reported in the journal Nature Medicine.

"This is a completely new pathway that contributes to the development of pain," said Dr Clifford Woolf of Massachusetts General Hospital and Harvard Medical School in Boston, who led the research.

"The study shows that we inherit the extent to which we feel pain, both under normal conditions and after damage to the nervous system." Chronic pain affects 1-in-5 adults or approximately 40 million Americans. The gene involved is called GCH1 that codes for an enzyme GTP cyclohydrolase that is required for the synthesis of a chemical called tetrahydrobiopterin or BH4.

"Our results tell us that BH4 is a key pain-producing molecule - when it goes up, patients experience pain, and if it is not elevated, they will have less pain," Woolf said in a statement. "The data also suggest that individuals who say they feel less pain are not just stoics but genuinely have inherited a molecular machinery that reduces their perception of pain. This difference results not from personality or culture, but real differences in the biology of the sensory nervous system."

Woolf and researchers in Germany and at the US National Institutes of Health said, "Rats with pain caused by nerve damage had higher levels of GCH1 gene activity and of BH4." The rats appeared to be less sensitive to pain when injecting a drug blocked the enzyme GTP cyclohydrolase. On th e other hand, augmented pain sensitivity was observed when BH4 was injected.

They conducted a study on 400 healthy individuals. They found that people with two copies of the protective version of "GCH1" were less sensitive to pain in tests, whereas those with only one copy had intermediate risk of developing chronic pain and those without any copy of the variant were at the highest risk.

"The drug used in the study, DAHP, is not very strong and is unlikely to be useful as a human medication, " said Woolf, who owns stock in a company called Solace Pharmaceuticals, which has licensed the findings for potential drug development.
GYT
'"/>




Related medicine news :

1. Viscosity of Women cervix determines sex of child
2. HIV Type determines turn-out of the disease.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of the ... this weekend’s Big Game. Take the stress out of your party preparation – follow ... happy at every stage of the game. , “The key to hosting a successful ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... Care for Patients with Rare Diseases, a continuing medical education (CME) event presented ... the first of its kind—and a first for ACCORD, whose mission is to ...
(Date:2/5/2016)... ... 05, 2016 , ... When one is tired of trying to cram belongings into spare space ... to rent a storage unit, but before hastily spending money on a unit, take these ... more space. But what one is often not told when utilizing these services are some ...
(Date:2/4/2016)... ... February 04, 2016 , ... True Health Initiative (THI), ... the creation of the THI Media Response Team (MRT). The primary mission of the ... and influencers about the fundamentals of healthy, sustainable eating, and other aspects of lifestyle ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... offering of 11,027,558 shares of its common stock by ... and Goldman Sachs.  The shares are being sold to ... share. The selling stockholders will receive all of the ... of its directors, officers or other stockholders is selling ...
(Date:2/5/2016)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... dental, animal health and medical practitioners, announced today that ... majority ownership interest in Dental Cremer S.A., a distributor ... . --> ... dental distribution business of Cremer S.A. With 2015 sales ...
Breaking Medicine Technology: